TÜ HIV rühm
Ettekanded
2017
Avi, R; Pauskar, M; Rajasaar, H; Kallas, E; Jõgeda, E; Soodla, P; Lutsar, I; Huik, K; Virologic responce to antiretroviral treatment in an Eastern European cohort study USA, Seattle, veebr 2017 (posterettekanne)
Huik, K; Soodla,P; Pauskar, M; Rajasaar, H; Jõgeda, E; Kallas, E; Avi, R; Lutsar, I. The evaluation of two HIV-1 incidence assays in subjecys infected with non-B subtype viruses Austria, Viin, aprill 2017 (posterettekanne)
2015
Kallas, E.; Avi, R.; Huik, K.; Türk, S.; Pauskar, M.; Jõgeda, E.-.L.; Šunina, M.; Des Jarlais, D.; Uusküla, A.; Lutsar, I. (2015). The distribution of TEMRA cells is influenced by HIV, HBV, HCV infections and intravenous drug use. 25th European Congress of Clinical Microbiology and Infectious Diseases; Copenhagen, Denmark, 25.-28. April 2015.
Pauskar, M; Avi, R.; Kallas, E.; Jõgeda, E-L.; Karki, T.; Uusküla, A.; Des Jarlais, D; Lutsar, I.; Huik, K. Association between IL28B rs12979860 genotypes and susceptibility to HCV and/or HIV infection in Caucasian intravenous drug users. 25th European Congress of Clinical Microbiology and Infectious Diseases; Copenhagen, Denmark, 25.-28. April 2015.
Kase, K.; Rajasaar, H.; Avi, R.; Pauskar, M.; Zilmer, K.; Kink, K.; Novikova, L.; Maimets, M.; Lutsar, I.; Huik, K. Co-infection with hepatitis C virus in Estonian HIV population during last two decades. 25th European Congress of Clinical Microbiology and Infectious Diseases; Copenhagen, Denmark, 25.-28. April 2015.
Soodla, P.; Rajasaar, H.; Maimets, M.; Lutsar, I. The Estonian HIV Cohort Study: Participant Characteristics Over Time. 25th European Congress of Clinical Microbiology and Infectious Diseases; Copenhagen, Denmark, 25.-28. April 2015.
2014
Avi, R.; Huik, K.; Pauskar, M.; Kallas, E.; Jõgeda, E.-L.; Zilmer, K.; Ustina, V.; Novikova, L.; Karki, T.; Kisand, V.; Lutsar, I. (2014). Full-Length Genome Sequences of Estonian HIV-1 CRF06 and Eastern-European Subtype A1 Recombinant Forms. 7th National Congress HIV/AIDS and the 2nd Central European HIV Forum, Sibiu, Romania, 29-31 May 2014.
Jõgeda, E.-L.; Huik, K.; Avi, R; Pauskar, M., Kallas, E.; Karki, T.; Marsh, K.; Des Jarlais, D.; Uusküla, A.; Lutsar, I. (2014). Associations between MX2 polymorphism and the acquisition of HIV and co-infections in Caucasian intravenous drug users (IDUs). European Human Genetics Conference 2014, Milan, Italy, 31 May-3 June 2014.
Kallas, E.; Avi, R.; Huik, K.; Türk, S.; Pauskar, M.; Jõgeda, E.-.L.; Šunina, M.; Des Jarlais, D.; Uusküla, A.; Lutsar, I. (2014). Injection drug use influences T-cell distribution and CCR5 expression in HIV+ and ESN population. 24th European Congress of Clinical Microbiology and Infectious Diseases; Barcelona; 10-13 May 2014.
Kallas, E.; Huik, K.; Avi, R; Pauskar, M.; Jõgeda, E.-L.; Karki, T.; Marsh, K.; Des Jarlais, D.; Uusküla, A.; Lutsar, I. (2014). NLRP3 genotype CG increases the risk of HIV-1 in Caucasian intravenous drug users (IDUs). European Human Genetics Conference 2014, Milan, Italy, 31 May-3 June 2014.
Pauskar, M.; Huik, K.; Avi, R.; Kallas, E.; Jõgeda, E.-L.; Karki, T.; Semjonova, S.; Smidt, J.; Novikova, L.; Ainsalu, K.; Lutsar, I. (2014). Antiretroviral drug resistance and viral tropism in HIV-1 CRF06_cpx infected patients failing antiretroviral (ARV) therapy. 7th National Congress HIV/AIDS and the 2nd Central European HIV Forum, Sibiu, Romania, 29-31 May 2014.
2013
Avi, R; Huik, K; Pauskar, M; Kallas, E; Jõgeda, EL; Karki, T; Šmidt, J; Novikova, L; Semjonova, S; Lutsar, I. (2013). Substitutions in RNaseH and Connection domain of HIV-1 CRF06_cpx viruses in treatment naive and treatment experienced populations. 11th European Meeting on HIV & Hepatitis- Treatment Strategies & Antiviral Drug Resistance; Rome; 20-22 March 2013, 35 – 35.
Jõgeda, EL; Huik, K; Pauskar, M; Kallas, E; Krispin, T; Karki, T; Marsh, K; Des Jarlais, D; Uusküla, A; Avi, R; Lutsar, I. (2013). The prevalence of GBV-C and its associations with HIV infection among Estonian intravenous drug users. In: Reviews in Antiviral Therapy Infectious Diseases: 11th European Meeting on HIV & Hepatitis- Treatment Strategies & Antiviral Drug Resistance; Rome; 20-22 March 2013, 46 – 47.
Kallas, E; Huik, K; Avi, R; Pauskar, M; Jõgeda, EL; Karki, T; Marsh, K; Des Jarlais, D; Uusküla, A; Lutsar, I (2013). The IL-10 promoter genotype AA at -592 is correlated with increased susceptibility to hepatitis B but not HIV infection in Caucasian intravenous drug users. European Human Genetics Conference 2013, Paris, France, 8.06.13-11.06.13.
2012
Avi, R.; Huik, K.; Pauskar, M., Lutsar, I.; Vandamme, A.; Abecasis, A. (2012). The population dynamics of the HIV-1 epidemic in Estonia through virus genetic analysis and national case recording. 17th International BioInformatics Workshop on Virus Evolution and Molecular Epidemiology, 27-31 August 2012 Belgrade Serbia.
Avi, R.; Huik, K.; Pauskar, M.; Kallas, E.; Karki, T.; Krispin, T.; Ainsalu, K.; Semjonova, S.; Kool, P.; Novikova, L.; Schmidt, J.; Lutsar, I. (2012). The pattern of drug resistance mutations in HIV-1 CRF06_cpx viruses failing the first-line NNRTI+2NRTI antiretroviral therapy. 10th European Meeting on HIV & Hepatitis – Treatment Strategies & Antiviral Drug Resistance, 28 – 30 March 2012 Barcelona Spain.
Kallas, E.; Avi, R.; Huik, K.; Pauskar, M.; Ustina, V.; Karki, T.; Krispin, T.; Ainsalu, K.; Semjonova, S.; Kool, P.; Novikova, L.; Schmidt, J.; Lutsar, I. (2012). HIV Type-1 CRF06_cpx P(T/S)AP Late Domain duplications are outselected among treatment experienced compared to treatment naïve patients. Reviews in Antiviral Therapy & Infectious Diseases.
Pauskar, M.; Avi, R.; Huik, K.; Ustina, V.; Jõgeda, E.; Kallas, E.; Karki, T.; Krispin, T.; Lutsar, I. (2012). Transmitted drug resistance is 4.5% in newly diagnosed mainly HIV-1 CRF06_cpx infected patients in Estonia in 2010. 10th European Meeting on HIV & Hepatitis – Treatment Strategies & Antiviral Drug Resistance, 28 – 30 March 2012 Barcelona Spain.
Uibopuu, H.; Huik, K.; Avi, R.; Pauskar, M.; Kallas, E.; Karki, T.; Krispin, T.; Kool, P.; Schmidt, J.; Rüütel, K.; Talu, A.; Abel-Ollo, K.; Uusküla, A.; Lutsar, I. (2012). Viral tropism of HIV-1 CRF06_cpx and its association with CCR5 haplotypes. 10th European Meeting on HIV & Hepatitis – Treatment Strategies & Antiviral Drug Resistance, 28 – 30 March 2012 Barcelona Spain.
2009
Huik, K.; Avi, R.; Sadam, M.; Karki, T.; Denks, K.; Krispin, T.; Ustina, V.; Rüütel, K.; Uusküla, A.; Murphy, G.; Lutsar, I. (2009). Performance of the BED-CEIA in population infected with HIV1 recombinant viruses CRF06cpx and CRF06A. In: Clinical Microbiology and Infection: 19th European Congress of Clinical Microbiology and Infectious Diseases Helsinki, Finland, 16 – 19 May 2009.
2008
Avi, R.; Huik, K.; Karki, T.; Sadam, M.; Krispin, T.; Ainsalu, K.; Paap, P.; Schmidt, J.; Nikitina, N.; Lutsar, I. (2008). Drug Resistance Mutations and Genetic Barrier for Drug Resistance Development in Estonian HIV-1 CRF06_cpx Integrase Sequences. 14th International Bioinformatics Workshop on Virus Evolution and Molecular Epidemiology; Cape Town, South Africa; 1-5 September 2008.
Avi, R.; Huik, K.; Sadam, M.; Karki, T.; Krispin, T.; Paap, P.; Ainsalu, K.; Schmidt, J.; Nikitina, N.; Lutsar, I. (2008). Natural polymorphisms associated with integrase inhibitor drug resistance in Estonian HIV-1 CRF06_cpx strains. 18th European Congress of Clinical Microbiology and Infectious Diseases; Barcelona; 19.04-22.04.2008.
Huik, K.; Avi, R.; Sadam, M.; Karki, T.; Albert, J.; Lutsar, I. (2008). Drug Resistance Mutations in HIV-1 CRF06_cpx Viruses Isolated from Treatment Naïve and Experienced Patients. In: European Journal of Medical Research: 19th European Students’ Conference; Berlin; 28 September – 3 October 2008.
Sadam, M.; Karki, T.; Huik, K.; Avi, R.; Rüütel, K.; Uusküla, A.; Lutsar, I (2008). CCL3L1 Variable Gene Copy Number Influence on the Susceptibility to HIV-1/AIDS Among Estonian Intravenous Drug User. The 15th Conference on Retroviruses and Opportunistic Infections (CROI), Boston, 03.02-06.02.2008.
2007
Avi, R.; Huik, K.; Karki, T.; Sadam, M.; Paap, P.; Smidt, J.; Ainsalu, K.; Krispin, T.; Lutsar, I (2007). The coexistence of secondary PR mutations M36I, K20I and L63H predominates in CRF06_cpx and its next generation recombinant virusese circulating in Estonian treatment naive patients. In: International Journal of Antimicrobial Agents, S549 – S549.
Denks, K.; Huik, K.; Avi, R.; Sadam, M.; Krispin, T.; Lutsar, I. (2007). GB virus C infection among HIV-positive patients in Estonia. International Journal of Antimicrobial Agents, 29(3), S155 – S155.
